Single dose pharmacokinetics of lamivudine in healthy volunteers: comparison of blood and urine kinetics

Ramachandran, G. ; Hemanth Kumar, A. K. ; Venkatesan, V. ; Anitha, S. ; Tharani, C. B. ; Kumaraswami, V. ; Swaminathan, S. (2008) Single dose pharmacokinetics of lamivudine in healthy volunteers: comparison of blood and urine kinetics SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, 5 (2). pp. 6-9. ISSN 1818-9741

Full text not available from this repository.

Official URL: http://nepjol.info/index.php/SAARCTB/article/view/...

Related URL: http://dx.doi.org/10.3126/saarctb.v5i2.3069

Abstract

Aim: To study single dose pharmacokinetics of lamivudine (3TC) in healthy subjects. Methods: Twelve healthy subjects were administered 3TC (150 mg) followed by timed blood and urine collections up to 24 hours. Pharmacokinetic variables and percent dose of 3TC in urine were calculated. Results: Plasma exposure and percent dose of 3TC in urine were highly correlated (p < 0.001; r = 0.96). 3TC concentration at 24 hours was undetectable in all study subjects. Conclusions: Timed urine measurements could be used to study bioavailabilty of 3TC. Plasma 3TC measurements could be used to monitor adherence among HIV-infected patients on antiretroviral treatment.

Item Type:Article
Source:Copyright of this article belongs to SAARC TB and HIV/AIDS Centre.
Keywords:Lamivudine; Plasma; Urine; Compliance to Treatment
ID Code:110220
Deposited On:01 Sep 2017 09:23
Last Modified:01 Sep 2017 09:23

Repository Staff Only: item control page